AFP and hepatocellular carcinoma: With continuous efforts being made to improve the performance of AFP-L3 by combining it with other biomarkers, some method like the GALAD score which entails age, sex, AFP, AFP-L3, and DCP has shown significant improvement in diagnostic performance for early-stage HCC.